Enrichment Strategy for Systemic Sclerosis Clinical Trials Targeting Skin Fibrosis: A Prospective, Multiethnic Cohort Study

OBJECTIVE: The modified Rodnan skin score (mRSS) is often used as a primary outcome measure in systemic sclerosis (SSc) randomized clinical trials (RCTs). Previous cohort studies with predominantly European Caucasian patients showed that setting an upper limit of mRSS as a selection criterion for RC...

Descripción completa

Detalles Bibliográficos
Autores principales: Mihai, Carina, Dobrota, Rucsandra, Assassi, Shervin, Mayes, Maureen D., Distler, Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437132/
https://www.ncbi.nlm.nih.gov/pubmed/32720753
http://dx.doi.org/10.1002/acr2.11165

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437132/
https://www.ncbi.nlm.nih.gov/pubmed/32720753
http://dx.doi.org/10.1002/acr2.11165

Ejemplares similares